theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hematology

Genitourinary Cancers   

Questions discussed in this category


Would you offer definitive radiotherapy for prostate cancer (or another solid organ malignancy) to a patient on maintenance Rituximab for lymphoma?
Would you hold Rituximab during radiation therapy? If so, how long would you recommend hold Rituximab before starting RT?
2 Answers available

Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
1 Answer available

Would you start anticoagulation in a patient with RCC and related (tumor) thrombus with extension to renal vein and further?
3 Answers available

How do you manage anemia associated with belzutifan therapy?
1 Answer available

How do you manage drug-drug interactions between oral anticoagulants and the ARSI agents such as apalutamide and enzalutamide?
1 Answer available

Would you stop hydroxyurea for thrombocytosis in a prostate patient receiving radiation?
1 Answer available
3739212671161920722180437145


Papers discussed in this category


Radiation oncology (London, England), 2024 Aug 29
Targeted RT study: results on early toxicity of targeted therapies and radiotherapy.

HemaSphere, 2018 Nov 30
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.

Related Topics in Hematology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.